The next step will be to understand what's driving this diversity in different cancers and identify key drivermutations that are common throughout all parts of a tumour.
Some say that doctors need to do a better job of identifying the key drivermutations inside common tumors, using newfangled gene sequencing machines and other exotic technologies.